Prevalence of Guideline Discordant Aspirin use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement
Antithrombotic therapy guidelines change over time due to evolving research and available treatments. For concomitant aspirin in patients on vitamin K antagonists for ischemic stroke prevention in mechanical heart valves, guidelines have shifted. In 2020, citing the fact that previous studies included many patients with older-generation valve prostheses and acknowledging the increased risk of major bleeding, the American College of Cardiology (ACC) and American Heart Association (AHA) reversed their previous recommendations to routinely add aspirin to VKA therapy.
Source: The American Journal of Medicine - Category: General Medicine Authors: Brian Haymart, Xiaowen Kong, Mona Ali, Jordan K. Schaefer, James B. Froehlich, Noelle Ryan, Beverly Stallings, Geoffrey D. Barnes, Scott Kaatz Tags: Clinical Research Study Source Type: research
More News: Aspirin | Bleeding | Cardiology | Coumadin | General Medicine | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Ischemic Stroke | Jordan Health | Middle East Health | Stroke | Study | Vitamin K | Vitamins | Warfarin